BR112018011526A2 - compostos policíclicos como inibidores da tirosina quinase de bruton - Google Patents
compostos policíclicos como inibidores da tirosina quinase de brutonInfo
- Publication number
- BR112018011526A2 BR112018011526A2 BR112018011526-6A BR112018011526A BR112018011526A2 BR 112018011526 A2 BR112018011526 A2 BR 112018011526A2 BR 112018011526 A BR112018011526 A BR 112018011526A BR 112018011526 A2 BR112018011526 A2 BR 112018011526A2
- Authority
- BR
- Brazil
- Prior art keywords
- kinase inhibitors
- tyrosine kinase
- polycyclic compounds
- bruton tyrosine
- compounds
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 1
- 125000003367 polycyclic group Chemical group 0.000 title 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940043355 kinase inhibitor Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Abstract
a presente descrição refere-se a compostos da fórmula (i) como inibidores de quinase de bruton e sua preparação, bem como composições que compreendem compostos da fórmula (i). (i)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562265836P | 2015-12-10 | 2015-12-10 | |
| US62/265,836 | 2015-12-10 | ||
| PCT/US2016/065954 WO2017100662A1 (en) | 2015-12-10 | 2016-12-09 | Polycyclic compounds as inhibitors of bruton's tyrosine kinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018011526A2 true BR112018011526A2 (pt) | 2018-11-21 |
| BR112018011526B1 BR112018011526B1 (pt) | 2024-02-27 |
Family
ID=57681784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018011526-6A BR112018011526B1 (pt) | 2015-12-10 | 2016-12-09 | Composto policíclico como inibidores da tirosina quinase de bruton,seu uso e composição farmacêutica |
Country Status (29)
| Country | Link |
|---|---|
| US (4) | US10717745B2 (pt) |
| EP (2) | EP3719022A1 (pt) |
| JP (2) | JP6835846B2 (pt) |
| KR (1) | KR102103395B1 (pt) |
| CN (2) | CN113121562B (pt) |
| AR (1) | AR107042A1 (pt) |
| AU (1) | AU2016366541B2 (pt) |
| BR (1) | BR112018011526B1 (pt) |
| CA (1) | CA3007990C (pt) |
| CY (1) | CY1123263T1 (pt) |
| DK (1) | DK3386991T3 (pt) |
| EA (1) | EA035168B1 (pt) |
| ES (1) | ES2805835T3 (pt) |
| HR (1) | HRP20201193T1 (pt) |
| HU (1) | HUE049502T2 (pt) |
| IL (1) | IL259863B (pt) |
| JO (1) | JO3794B1 (pt) |
| LT (1) | LT3386991T (pt) |
| MA (2) | MA43409B1 (pt) |
| MD (1) | MD3386991T2 (pt) |
| ME (1) | ME03803B (pt) |
| MX (1) | MX2018007075A (pt) |
| PL (1) | PL3386991T3 (pt) |
| PT (1) | PT3386991T (pt) |
| RS (1) | RS60604B1 (pt) |
| SI (1) | SI3386991T1 (pt) |
| TW (1) | TWI729047B (pt) |
| UY (1) | UY37015A (pt) |
| WO (1) | WO2017100662A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3794B1 (ar) | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون |
| JO3793B1 (ar) | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | مثبطات تيروزين كاينيز بروتون وأساليب استخدامها |
| EP3596087A1 (en) * | 2017-03-15 | 2020-01-22 | Janssen Sciences Ireland Unlimited Company | Methods of selective aryl- and heteroaryl-nitrogen bond formation |
| CN108164397B (zh) * | 2018-01-18 | 2020-11-13 | 暨南大学 | 一类邻苯二酚衍生物及其制备方法 |
| EP3802537A1 (en) | 2018-06-11 | 2021-04-14 | Amgen Inc. | Kras g12c inhibitors for treating cancer |
| EP4089095A4 (en) | 2020-01-07 | 2024-03-27 | Medshine Discovery Inc | DEUTERATED THIENOPYRIDINE COMPOUND |
| AU2022231352A1 (en) | 2021-03-03 | 2023-10-19 | Janssen Pharmaceutica Nv | Combination therapy using a malt1 inhibitor and a btk inhibitor |
| IL308951A (en) | 2021-06-04 | 2024-01-01 | Janssen Pharmaceutica Nv | Inhibitors of proton tyrosine kinase and methods of using them |
| CA3223610A1 (en) | 2021-06-30 | 2023-01-05 | Janssen Pharmaceutica Nv | Inhibitors of bruton's tyrosine kinase and methods of their use |
| CA3227033A1 (en) | 2021-08-09 | 2023-02-16 | Eric Frederik ELDERING | Compositions for use in treating b-cell malignancies |
| WO2023156599A1 (en) * | 2022-02-18 | 2023-08-24 | Janssen Pharmaceutica Nv | Synthesis of bruton's tyrosine kinase inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3112415A1 (de) | 1981-03-28 | 1982-10-07 | Dynamit Nobel Ag, 5210 Troisdorf | Verfahren zur chlorierung von cyclischen amiden und cyclischen vinylogen amiden |
| US5430150A (en) | 1992-12-16 | 1995-07-04 | American Cyanamid Company | Retroviral protease inhibitors |
| US5300478A (en) | 1993-01-28 | 1994-04-05 | Zeneca Limited | Substituted fused pyrazolo compounds |
| JP2008513463A (ja) | 2004-09-15 | 2008-05-01 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | チアゾロピリジンキナーゼ阻害剤 |
| WO2006118749A1 (en) * | 2005-05-04 | 2006-11-09 | Janssen Pharmaceutica, N.V. | Thia-tetraazaacenaphthylene kinase inhibitors |
| US7605154B2 (en) | 2005-08-08 | 2009-10-20 | Janssen Pharmaceutica N.V. | Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors |
| WO2007092879A2 (en) * | 2006-02-08 | 2007-08-16 | Janssen Pharmaceutica, N.V. | Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| EP2081435B1 (en) | 2006-09-22 | 2016-05-04 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| US8598174B2 (en) * | 2008-11-12 | 2013-12-03 | Genetech, Inc. | Pyridazinones, method of making, and method of use thereof |
| WO2011024869A1 (ja) * | 2009-08-26 | 2011-03-03 | 武田薬品工業株式会社 | 縮合複素環誘導体およびその用途 |
| WO2011133609A2 (en) | 2010-04-19 | 2011-10-27 | The Translational Genomics Research Institute | Methods and kits to predict therapeutic outcome of btk inhibitors |
| FR2978441A1 (fr) | 2011-07-25 | 2013-02-01 | Diverchim | Nouveaux analogues de ceramides, leurs procedes de preparation et leurs applications dans les compositions pharmaceutiques et cosmetiques |
| DK2970291T3 (da) | 2013-03-15 | 2022-08-01 | Janssen Pharmaceutica Nv | Fremgangsmåder og mellemprodukter til fremstilling af et medikament |
| MX370103B (es) * | 2013-12-11 | 2019-12-02 | Biogen Ma Inc | Compuestos de biarilo utiles para el tratamiento de enfermedades humanas en oncologia, neurologia e inmunologia. |
| JO3793B1 (ar) | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | مثبطات تيروزين كاينيز بروتون وأساليب استخدامها |
| JO3794B1 (ar) | 2015-12-10 | 2021-01-31 | Janssen Pharmaceutica Nv | المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون |
| WO2018103060A1 (en) | 2016-12-09 | 2018-06-14 | Janssen Pharmaceutica Nv | Inhibitors of bruton's tyrosine kinase and methods of their use |
| WO2018103058A1 (en) | 2016-12-09 | 2018-06-14 | Janssen Pharmaceutica Nv | Inhibitors of bruton's tyrosine kinase and methods of their use |
-
2016
- 2016-12-08 JO JOP/2016/0256A patent/JO3794B1/ar active
- 2016-12-09 PT PT168201069T patent/PT3386991T/pt unknown
- 2016-12-09 MA MA43409A patent/MA43409B1/fr unknown
- 2016-12-09 WO PCT/US2016/065954 patent/WO2017100662A1/en active Application Filing
- 2016-12-09 ME MEP-2020-155A patent/ME03803B/me unknown
- 2016-12-09 EA EA201891378A patent/EA035168B1/ru unknown
- 2016-12-09 JP JP2018530000A patent/JP6835846B2/ja active Active
- 2016-12-09 PL PL16820106T patent/PL3386991T3/pl unknown
- 2016-12-09 US US15/374,905 patent/US10717745B2/en active Active
- 2016-12-09 HU HUE16820106A patent/HUE049502T2/hu unknown
- 2016-12-09 LT LTEP16820106.9T patent/LT3386991T/lt unknown
- 2016-12-09 AU AU2016366541A patent/AU2016366541B2/en active Active
- 2016-12-09 EP EP20177012.0A patent/EP3719022A1/en active Pending
- 2016-12-09 CA CA3007990A patent/CA3007990C/en active Active
- 2016-12-09 MD MDE20180978T patent/MD3386991T2/ro unknown
- 2016-12-09 CN CN202110404024.3A patent/CN113121562B/zh active Active
- 2016-12-09 MX MX2018007075A patent/MX2018007075A/es unknown
- 2016-12-09 EP EP16820106.9A patent/EP3386991B1/en active Active
- 2016-12-09 CN CN201680072125.2A patent/CN108884106A/zh active Pending
- 2016-12-09 ES ES16820106T patent/ES2805835T3/es active Active
- 2016-12-09 KR KR1020187018900A patent/KR102103395B1/ko active IP Right Grant
- 2016-12-09 DK DK16820106.9T patent/DK3386991T3/da active
- 2016-12-09 TW TW105140760A patent/TWI729047B/zh active
- 2016-12-09 BR BR112018011526-6A patent/BR112018011526B1/pt active IP Right Grant
- 2016-12-09 RS RS20200884A patent/RS60604B1/sr unknown
- 2016-12-09 SI SI201630825T patent/SI3386991T1/sl unknown
- 2016-12-09 UY UY0001037015A patent/UY37015A/es active IP Right Grant
- 2016-12-09 MA MA053110A patent/MA53110A/fr unknown
- 2016-12-12 AR ARP160103789A patent/AR107042A1/es unknown
-
2018
- 2018-06-07 IL IL259863A patent/IL259863B/en active IP Right Grant
-
2019
- 2019-05-15 US US16/413,453 patent/US10934310B2/en active Active
-
2020
- 2020-05-13 US US15/931,437 patent/US11319329B2/en active Active
- 2020-07-30 HR HRP20201193TT patent/HRP20201193T1/hr unknown
- 2020-08-18 CY CY20201100769T patent/CY1123263T1/el unknown
-
2021
- 2021-02-04 JP JP2021016602A patent/JP7072690B2/ja active Active
-
2022
- 2022-03-25 US US17/705,225 patent/US20230097422A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018011526A2 (pt) | compostos policíclicos como inibidores da tirosina quinase de bruton | |
| CO2017011851A2 (es) | Compuestos novedosos | |
| NI201600144A (es) | Derivados de quinoxalina utiles como moduladores del fgfr cinasa | |
| EA201890239A3 (ru) | Фумараты как пролекарства и их применение при лечении различных заболеваний | |
| GT201400178A (es) | Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks | |
| BR112018011525A2 (pt) | inibidores da tirosina quinase de bruton e métodos de seu uso | |
| CU20180001A7 (es) | Derivados de oxopiridina sustituidos y procesos para su preparación | |
| CR20150228A (es) | Inhibidores de la tirosina-quinasa de bruton | |
| TR201811764T4 (tr) | Kinaz inhibitörleri olarak aminoheteroaril benzamidleri. | |
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| UY35500A (es) | Indazoles sustituidos con heteroarilo | |
| UY35467A (es) | Compuestos orgánicos | |
| EA201492056A1 (ru) | Пиримидиниловые ингибиторы тирозинкиназы | |
| EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
| BR112018014705A2 (pt) | inibidores de tirosina quinase de bruton | |
| EA201500801A1 (ru) | Бензохинолоновые ингибиторы vmat2 | |
| DOP2018000062A (es) | Piridinona dicaboxamidas para uso como inhibidores de bromodominio | |
| CR20170008A (es) | Compuestos de [1,2,4] triazol e imidazol sustituidos | |
| BR112019021867A2 (pt) | Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenil | |
| CR20150440A (es) | Nuevos derivados de piridina | |
| DOP2015000176A (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| CR20160448A (es) | Nuevos derivados de piridina | |
| CR20170090A (es) | Derivados de terahidroquinolina como inhibidores del bromodominio | |
| BR112016028022A2 (pt) | compostos de sulfonamida e seus usos como inibidores de stat5 | |
| BR112017011285A2 (pt) | compostos intermediários para produzir ingredientes de perfumaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/12/2016, OBSERVADAS AS CONDICOES LEGAIS |